Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

Bruno de Paula; Olivier Cexus; Paul Townsend; Susanne Crocamo

doi:10.1016/j.asjsur.2024.07.024

Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

Bruno de Paula^*, Olivier Cexus, Paul Townsend, Susanne Crocamo

^*Corresponding author for this work

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Asian journal of surgery
Early online date	23 Jul 2024
DOIs	https://doi.org/10.1016/j.asjsur.2024.07.024
Publication status	E-pub ahead of print - 23 Jul 2024

Keywords

Her2-positive breast cancer
Pathological complete response rate
Zoledronic acid

Access to Document

10.1016/j.asjsur.2024.07.024Licence: CC BY-NC-ND

Cite this

@article{1b46a68f34da4be082a0e872c3d9535a,

title = "Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer",

keywords = "Her2-positive breast cancer, Pathological complete response rate, Zoledronic acid",

author = "{de Paula}, Bruno and Olivier Cexus and Paul Townsend and Susanne Crocamo",

year = "2024",

month = jul,

day = "23",

doi = "10.1016/j.asjsur.2024.07.024",

language = "English",

journal = "Asian journal of surgery",

issn = "1015-9584",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

AU - de Paula, Bruno

AU - Cexus, Olivier

AU - Townsend, Paul

AU - Crocamo, Susanne

PY - 2024/7/23

Y1 - 2024/7/23

KW - Her2-positive breast cancer

KW - Pathological complete response rate

KW - Zoledronic acid

UR - http://www.scopus.com/inward/record.url?scp=85200848323&partnerID=8YFLogxK

U2 - 10.1016/j.asjsur.2024.07.024

DO - 10.1016/j.asjsur.2024.07.024

M3 - Letter

AN - SCOPUS:85200848323

SN - 1015-9584

JO - Asian journal of surgery

JF - Asian journal of surgery

ER -

Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer

Keywords

Access to Document

Other files and links

Cite this